Aron Knickerbocker leverages his Big Pharma credentials to launch successful biotech startups, including his most recent venture, Aulos, which uses AI to accelerate drug development.

Aulos Bioscience is leading the pack in a crowded race to revolutionize cancer treatment with its AI-generated antibody, the first to be tested in human clinical trials.

US-based immuno-oncology company Aulos Bioscience has announced the first patients have been dosed as part of a trial investigating avelumab, marketed as Bavencio by its original developer Merck ...

The reference information listed below is intended for those who work with the Getty's data. This information comes from the Museum's collection database, and in some cases is incomplete or awaiting ...

ProTip! Mix and match filters to narrow down what you’re looking for.